z-logo
open-access-imgOpen Access
Mepolizumab decreased the levels of serum galectin-10 and eosinophil cationic protein in asthma
Author(s) -
Konomi Kobayashi,
Hiroyuki Nagase,
Naoya Sugimoto,
Shiho Yamamoto,
Akihiko Tanaka,
Koichi Fukunaga,
Ryo Atsuta,
Etsuko Tagaya,
Masayuki Hojo,
Yasuhiro Gon
Publication year - 2021
Publication title -
asia pacific allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.179
H-Index - 6
eISSN - 2233-8268
pISSN - 2233-8276
DOI - 10.5415/apallergy.2021.11.e31
Subject(s) - mepolizumab , medicine , eosinophil cationic protein , eosinophil , asthma , exhaled nitric oxide , eosinophil granule proteins , immunology , interleukin 5 , galectin 3 , immunoglobulin e , gastroenterology , antibody , interleukin , cytokine , bronchoconstriction

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom